ADVFN US – Market Content Editor
-

U.S. Stocks Finish Volatile Session Sharply Higher
After showing a strong move to the upside early in the session, stocks saw significant volatility over the course of the trading day on Wednesday. The major averages largely gave back their early gains in late morning trading before experiencing an afternoon resurgence and ending the day sharply higher. The major averages all posted strong…
-

Mexico becomes first Latin American operator of Lockheed’s C-130J Super Hercules
Mexico has become the first country in Latin America to field the C-130J Super Hercules, after the Fuerza Aérea Mexicana (FAM) confirmed the purchase of its first C-130J-30 tactical airlifter from Lockheed Martin (NYSE:LMT). The deal is one of two international C-130J contract awards finalized in 2025, with the second overseas customer yet to be…
-

Vertical Aerospace and Bristow Group gain as companies outline Manhattan air taxi concept
Shares of Vertical Aerospace Ltd (NYSE:EVTL) rose 3.1% on Wednesday, while Bristow Group Inc (NYSE:VTOL) advanced 3.3%, after the two companies unveiled plans for electric air taxi routes serving New York City that could sharply cut travel times in and out of Manhattan. The proposal envisions linking hubs such as John F. Kennedy International Airport…
-

Lemonade jumps after unveiling insurance tailored to Tesla Full Self-Driving users
Shares of Lemonade Inc (NYSE:LMND) climbed 6.3% on Wednesday after the digital insurer introduced a new policy designed specifically for Tesla vehicles equipped with Full Self-Driving (FSD) technology. The company said the product is the first of its kind and will reduce per-mile insurance rates by roughly 50% when Tesla’s FSD system is active. The…
-

Aligos Therapeutics edges higher after update on Phase 2 HBV trial
Shares of Aligos Therapeutics Inc (NASDAQ:ALGS) rose 3.1% on Wednesday after the company provided a progress update on its Phase 2 B-SUPREME study evaluating pevifoscorvir sodium for the treatment of chronic hepatitis B virus (HBV) infection. The clinical-stage biopharmaceutical firm said 144 patients have now been enrolled globally, achieving enrollment targets required for both planned…
-

Xerox shares sink after company unveils plans for up to $250 million securities sale
Shares of Xerox Holdings Corporation (NASDAQ:XRX) slid 13.7% on Wednesday after the workplace technology group disclosed plans to raise as much as $250 million through a securities offering. The sharp sell-off followed the release of a prospectus outlining potential issuances of common stock and warrants. In the filing, Xerox said the securities could be sold…
-

Hoth Therapeutics gains after winning China patent for HT-KIT cancer program
Shares of Hoth Therapeutics Inc (NASDAQ:HOTH) advanced 3.6% in premarket trading on Wednesday after the clinical-stage biopharmaceutical company said it has been granted an important patent in China related to its HT-KIT oncology program. The patent was approved by the China National Intellectual Property Administration and covers Hoth’s HT-KIT technology, which is designed to trigger…
-

Lucid Diagnostics jumps after landing VA agreement for EsoGuard cancer screening
Shares of Lucid Diagnostics Inc (NASDAQ:LUCD) rose 12.4% in premarket trading on Wednesday after the company said it had won a contract with the U.S. Department of Veterans Affairs (VA) covering its EsoGuard Esophageal DNA Test. The deal broadens access to Lucid’s esophageal precancer screening across the VA’s nationwide healthcare network, which provides care to…
-

Lisata Therapeutics surges on Kuva Labs takeover proposal carrying hefty premium
Shares of Lisata Therapeutics Inc (NASDAQ:LSTA) jumped nearly 85% in premarket trading on Wednesday after the clinical-stage drug developer said it has signed a binding term sheet to be acquired by privately held Kuva Labs, Inc. Under the proposed deal, Kuva Labs plans to launch a tender offer to acquire all outstanding Lisata shares for…
-

Nathan’s Famous jumps after Smithfield Foods tables $102-a-share takeover bid
Shares of Nathan’s Famous Inc (NASDAQ:NATH) surged 9.6% in premarket trading on Wednesday after Smithfield Foods Inc (NASDAQ:SFD) unveiled an all-cash proposal to buy the hot dog brand for $102.00 per share. The transaction places an enterprise value of roughly $450 million on Nathan’s Famous and would give Smithfield permanent ownership of the brand, which…